Genomics’ Proprietary Statistical Analysis Tools and Integrated Multi-Phenotype Database to be used to Support Research and Development at Vertex Pharmaceuticals.

Genomics plc has entered into a collaboration agreement with Biogen. The collaboration aims to refine drug target selection through the use of sophisticated analysis of human genetic data.

Eisai and Genomics plc today announce a collaborative agreement to use Genomics’ sophisticated statistical analyses of large-scale multi-phenotype genetic association data to inform Eisai’s drug discovery process.

Nature article: History revealed in Britain’s genes.

Genomics has secured £2m to develop its genome analysis platform in a Small Business Research Initiative (SBRI) competition.

IP Group plc portfolio company and University of Oxford spin-out raises £10.3m.

Nature article: Spreading the genomic net.

Genomics’ Proprietary Statistical Analysis Tools and Integrated Multi-Phenotype Database to be used to Support Research and Development at Vertex Pharmaceuticals.

Genomics plc has entered into a collaboration agreement with Biogen. The collaboration aims to refine drug target selection through the use of sophisticated analysis of human genetic data.

Eisai and Genomics plc today announce a collaborative agreement to use Genomics’ sophisticated statistical analyses of large-scale multi-phenotype genetic association data to inform Eisai’s drug discovery process.

Nature article: History revealed in Britain’s genes.

Genomics has secured £2m to develop its genome analysis platform in a Small Business Research Initiative (SBRI) competition.

IP Group plc portfolio company and University of Oxford spin-out raises £10.3m.

Nature article: Spreading the genomic net.

Genomics’ Proprietary Statistical Analysis Tools and Integrated Multi-Phenotype Database to be used to Support Research and Development at Vertex Pharmaceuticals.

Genomics plc has entered into a collaboration agreement with Biogen. The collaboration aims to refine drug target selection through the use of sophisticated analysis of human genetic data.

Eisai and Genomics plc today announce a collaborative agreement to use Genomics’ sophisticated statistical analyses of large-scale multi-phenotype genetic association data to inform Eisai’s drug discovery process.

Nature article: History revealed in Britain’s genes.

Genomics has secured £2m to develop its genome analysis platform in a Small Business Research Initiative (SBRI) competition.

IP Group plc portfolio company and University of Oxford spin-out raises £10.3m.

Nature article: Spreading the genomic net.